Neucore Bio

About Neucore Bio

Neucore Bio is dedicated to engineering the future of precision genetic medicines and pioneering regenerative therapies for genetic diseases and dermatologic repair. Their mission is to harness the body's intercellular delivery processes to disrupt degenerative disease progression and address cellular mechanisms associated with skin dysfunction, delivering novel therapeutics for unmet needs in genetic disease and advanced functional skincare.

Products & Services

FiXE™ Platform:A proprietary Fibroblast-Derived Engineering Extracellular Vesicles platform that enables cell-targeted delivery of genetic therapeutics for complex diseases and next-generation functional skincare, using exosomes for precise RNA delivery and fibroblast regeneration.

Non-viral Genetic Medicines:Therapeutics for diseases of the peripheral nervous system using fibroblast-derived exosomes as a scalable, nonviral alternative to traditional viral vector therapies, targeting rare disease populations.

Regenerative Skincare Solutions:Precision therapeutics based on fibroblasts to repair the extracellular matrix and address aging-related skin decline at the cellular level, focusing on collagen, elastin, and hyaluronic acid production.

Specialties

Precision Genetic Medicines Regenerative Therapies Exosome-based Therapeutics Functional Skincare Non-viral Genetic Delivery Dermatology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: STTR Phase I Grant T: - FT: STTR Phase I Grant	A: 350000 MR: - FA: $350,000 FAN: 350000	D: 2025-09-02 FD: 2025-09-02	1 investors
2	RT: STTR Phase I Grant T: - FT: STTR Phase I Grant	A: 304000 MR: - FA: $304,000 FAN: 304000	D: 2025-08-06 FD: 2025-08-06	1 investors

STTR Phase I Grant Latest

2025-09-02

$350K

1 investor (Pro only)

STTR Phase I Grant 2025-08-06

$304K

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kenneth L. Morand

Co-founder and Chief Executive Officer

B

Brian Price

Co-founder / Chief Scientific Officer / Chief Technology Officer

P

Peter Kleinhenz

Co-founder / Chief Operating Officer / Chief Financial Officer

S

Silvia Duarte-Sanmiguel

R&D Director

M

Michael Triplett

Co-founder / Board Chair

D

Daniel Gallego-Perez

Scientific Co-founder

View 4 more team members with Pro

Unlock Full Team Directory

Recent News

Neucore Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised